These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2628129)

  • 41. Bypass compared with resection for ileal Crohn's disease.
    Koudahl G; Kristensen M; Lenz K
    Scand J Gastroenterol; 1974; 9(2):203-6. PubMed ID: 4818398
    [No Abstract]   [Full Text] [Related]  

  • 42. Lithogenic risk factors for renal stones in patients with Crohn's disease.
    Buño Soto A; Torres Jiménez R; Olveira A; Fernández-Blanco Herraiz I; Montero García A; Mateos Antón F
    Arch Esp Urol; 2001 Apr; 54(3):282-92. PubMed ID: 11432047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Near infrared spectrometry for faecal fat measurement: comparison with conventional gravimetric and titrimetric methods.
    Benini L; Caliari S; Guidi GC; Vaona B; Talamini G; Vantini I; Scuro LA
    Gut; 1989 Oct; 30(10):1344-7. PubMed ID: 2583563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Fecal chymotrypsin and steatorrhea in chronic pancreatitis].
    Montalto G; Carroccio A; Soresi M; Di Martino D; Ippolito S; La Rocca G; Notarbartolo A
    Minerva Gastroenterol Dietol; 1992; 38(1):15-9. PubMed ID: 1520749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Malabsorption is a major contributor to underweight in Crohn's disease patients in remission.
    Vaisman N; Dotan I; Halack A; Niv E
    Nutrition; 2006 Sep; 22(9):855-9. PubMed ID: 16928471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
    Campieri C; Campieri M; Bertuzzi V; Swennen E; Matteuzzi D; Stefoni S; Pirovano F; Centi C; Ulisse S; Famularo G; De Simone C
    Kidney Int; 2001 Sep; 60(3):1097-105. PubMed ID: 11532105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of urinary parameters as risk factors for nephrolithiasis in children with celiac disease.
    Saccomani MD; Pizzini C; Piacentini GL; Boner AL; Peroni DG
    J Urol; 2012 Aug; 188(2):566-70. PubMed ID: 22704115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Oxalate renal stones and gallstones after ileal resection for Crohn's disease (author's transl)].
    Capron JP; Dupas JL; Delamarre J; Joly JP; Abourachid H; Lorriaux A
    Gastroenterol Clin Biol; 1977 Feb; 1(2):165-9. PubMed ID: 873113
    [No Abstract]   [Full Text] [Related]  

  • 49. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.
    Scarpa M; D'Incà R; Basso D; Ruffolo C; Polese L; Bertin E; Luise A; Frego M; Plebani M; Sturniolo GC; D'Amico DF; Angriman I
    Dis Colon Rectum; 2007 Jun; 50(6):861-9. PubMed ID: 17473939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationships between the extent of ileal lesion of resection and vitamin B12, bile salt and fat absorption.
    Papazian A; Minaire Y; Descos L; Andre C; Melange M; Vignal J
    Hepatogastroenterology; 1981 Apr; 28(2):106-9. PubMed ID: 7216143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Determination of faecal fat in infants and children with bacterial and viral infections (author's transl)].
    Borkenstein M; Rossipal E
    Padiatr Padol; 1978; 13(2):145-51. PubMed ID: 643291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of a low- and a high-oxalate vegetarian diet on intestinal oxalate absorption and urinary excretion.
    Thomas E; von Unruh GE; Hesse A
    Eur J Clin Nutr; 2008 Sep; 62(9):1090-7. PubMed ID: 17609696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence and significance of faecal hydroxystearic acid in alimentary disease.
    Wiggins HS; Pearson JR; Walker JG; Russell RI; Kellock TD
    Gut; 1974 Aug; 15(8):614-21. PubMed ID: 4418840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Studies of dietary influence on urinary oxalate in calcium oxalate stone formers].
    Arima K
    Hinyokika Kiyo; 1983 Dec; 29(12):1587-603. PubMed ID: 6687143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crohn's disease and pancreatitis.
    Eisner TD; Goldman IS; McKinley MJ
    Am J Gastroenterol; 1993 Apr; 88(4):583-6. PubMed ID: 8470642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Studies on biliary and fecal bile acids in Crohn's disease (the 1st report)--comparison of non-resected and resected cases].
    Konno Y; Hiwatashi N; Kumagai Y; Azumi K; Hirakawa H; Miyakawa T; Amakasu J; Tanno N; Koizumi M; Goto Y
    Nihon Shokakibyo Gakkai Zasshi; 1985 Nov; 82(11):2742-51. PubMed ID: 4087481
    [No Abstract]   [Full Text] [Related]  

  • 57. [Medium chain triglycerides in the treatment of malabsorption disorders].
    Johansson C; Moberg S; Nilsson LH
    Nord Med; 1969 Jul; 82(30):921-5. PubMed ID: 5808583
    [No Abstract]   [Full Text] [Related]  

  • 58. [Serum beta-carotene: a simple static laboratory parameter for the diagnosis of steatorrhea].
    Lembcke B; Geibel K; Kirchhoff S; Lankisch PG
    Dtsch Med Wochenschr; 1989 Feb; 114(7):243-7. PubMed ID: 2917485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fecal calprotectin one year after ileocaecal resection for Crohn's disease--a comparison with findings at ileocolonoscopy.
    Lasson A; Strid H; Ohman L; Isaksson S; Olsson M; Rydström B; Ung KA; Stotzer PO
    J Crohns Colitis; 2014 Aug; 8(8):789-95. PubMed ID: 24418661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Steatocrit: a reliable semiquantitative method for detection of steatorrhea.
    Sugai E; Srur G; Vazquez H; Benito F; Mauriño E; Boerr LA; Bai JC
    J Clin Gastroenterol; 1994 Oct; 19(3):206-9. PubMed ID: 7806830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.